Jason Murphy, Head of Pharmacy at Chemist4U The bottom line Oral GLP-1s are delivering significant weight loss results in clinical trials, with many patients achieving the kind of weight reduction that can meaningfully improve long-term health
Sarah's Experience with Semaglutide Starting Treatment: First Doses and Adjustments In November 2022, Sarah began her journey with Semaglutide, starting at a weekly dose of 0.25 mg
Happy Holidays ahead, and we cannot wait to see you again
Again, its interesting to see how the wise and very useful regulations are potentially holding back progress
The goal is not rapid transformation but gradual improvements that support long-term health and quality of life
Peters MC, Mauger D, Ross KR, et al